Group 1 - The core viewpoint of the news highlights a significant increase in the CSI 500 Free Cash Flow Index, which rose over 3.2%, with specific stocks like Silver Nonferrous and Zhejiang Longsheng hitting the daily limit [1] - The CSI 500 Free Cash Flow ETF (560120) has seen a rise of over 3.7%, marking an 8-day consecutive increase, and has attracted a net inflow of over 79.9 million yuan in the past 10 days [1] - The index employs a quarterly adjustment mechanism to dynamically update its sample based on the latest financial data, effectively removing companies with negative or declining cash flow quality, thus enhancing its "metabolic" capability and reducing long-term holding risks [1] Group 2 - Western Securities notes that during the Kondratiev wave downturn, increased geopolitical uncertainty has led to a natural preference for gold or stable cash flow "safe assets," which has re-evaluated the dividend strategy in the A-share market [2] - The cash flow strategy has outperformed dividends in the current market, as the "anti-involution + capital repatriation" trend is restoring corporate free cash flow [2] - As of December 31, 2025, the top ten weighted stocks in the CSI 500 Free Cash Flow Index include CIMC, Shougang, Silver Nonferrous, and Zhejiang Longsheng, collectively accounting for 44.11% of the index [2]

Core Viewpoint - The stock price of Gaoshi Medical (02407) has experienced fluctuations following its removal from the Hong Kong Stock Connect list, with a significant increase of 65.50% from May to September last year, but has since faced a decline of nearly 20% since December 22, raising questions about its upcoming performance in the 2025 annual report [1][2]. Group 1: Stock Performance - After being removed from the Hong Kong Stock Connect list, Gaoshi Medical's stock price initially rose, achieving a monthly "four consecutive increases" [1]. - The stock price saw a cumulative increase of 65.50% from May to September last year, but began a three-month period of sideways movement starting in mid-September [1]. - Since December 22, the stock has declined nearly 20%, effectively reversing all gains made since the mid-year report [1]. Group 2: Market Dynamics - On March 10, the adjustment of the Hong Kong Stock Connect list led to an average stock price drop of 14.24% for the excluded stocks, with Gaoshi Medical being one of them [1]. - Despite the stock's removal, the proportion of shares held by Hong Kong Stock Connect investors has only decreased by 3% over the past 10 months, indicating limited selling pressure [2]. - The liquidity of Gaoshi Medical's stock has noticeably decreased post-removal, with monthly trading volumes dropping by 84.39% from February to April last year [4]. Group 3: Financial Performance - In 2024, Gaoshi Medical reported revenues of 1.428 billion yuan, a year-on-year increase of 1.6%, but net profit fell by 46.75% to 92.394 million yuan due to factors like currency fluctuations and goodwill impairment [7]. - The company has been attempting to adjust its business structure by increasing the proportion of self-owned products, but the revenue from agency products rebounded to 68.55% in 2024 [8]. - In the first half of 2025, Gaoshi Medical achieved revenues of 653 million yuan, a 1.7% increase year-on-year, with a gross profit margin of 48.3%, reflecting an improvement [9]. Group 4: Future Outlook - Analysts project that Gaoshi Medical's revenues will grow to 1.564 billion, 1.715 billion, and 1.875 billion yuan from 2025 to 2027, with corresponding net profits of 135 million, 180 million, and 214 million yuan [9]. - Following the release of the mid-year report, Gaoshi Medical's stock price surged by 19.31% over two days, indicating positive market sentiment towards its performance [9]. - The current trading volume and price movements suggest that the stock may be nearing a bottom, with potential for recovery as market conditions improve [10].

Core Viewpoint - *ST Shengxun (003004.SZ) forecasts a net profit attributable to shareholders of the parent company for 2025 to be between -6 million and -12 million yuan, showing an improvement from -51.2 million yuan in the same period last year [1] Financial Performance Summary - The company expects 2025 annual revenue to be between 365 million and 415 million yuan [1] - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between -7.3 million and -13.3 million yuan, compared to -55.3 million yuan in the previous year [1] - The total profit for 2025 is expected to be between -6 million and -3 million yuan, reflecting an 88.9% increase compared to the previous year [2] - The net profit attributable to shareholders is projected to improve by 75.56% compared to last year, with estimates between -12 million and -6 million yuan [2] - The net profit after deducting non-recurring gains and losses is expected to show a 75.93% increase, with estimates between -13.3 million and -7.3 million yuan [2] Historical Financial Data - In 2024, the company achieved a revenue of 302 million yuan, a year-on-year increase of 7.85% [2] - The net profit attributable to shareholders for 2024 was -51 million yuan, compared to 25 million yuan in the previous year [2] - The net cash flow from operating activities for 2024 was -5.6 million yuan, down from -0.1 million yuan in the previous year [2] Company Background - *ST Shengxun was listed on the Shenzhen Stock Exchange on November 26, 2020, with an initial public offering of 20.46 million shares at a price of 20.26 yuan per share [3] - The total amount raised from the IPO was 415 million yuan, with a net amount of 378 million yuan after expenses [3] - The company issued 2.8 million convertible bonds in December 2022, raising a total of 280 million yuan [3]

Group 1 - The core viewpoint of the articles emphasizes the strong performance of high cash flow sectors such as oil, petrochemicals, and non-ferrous metals, with the National Free Cash Flow Index rising by 2.59% as of January 28, 2026 [1] - Regulatory bodies are reinforcing dividend requirements for listed companies, encouraging firms to enhance investor returns, which highlights the value of companies that can consistently generate substantial free cash flow [1] - The cash flow strategy is noted to outperform traditional high dividend strategies, focusing on sustainable cash generation capabilities, which aligns with the deeper value investment philosophy [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the National Free Cash Flow Index include China National Offshore Oil Corporation, SAIC Motor, Gree Electric Appliances, and others, collectively accounting for 51.95% of the index [2] - The cash flow ETF managed by Harvest (159221) closely tracks the National Free Cash Flow Index, creating a combination of profitability quality and dividend potential [2] - Investors can also access opportunities through the cash flow ETF Harvest's off-market connection (024574) [3]

Core Viewpoint - The decline in shares of Mixue Group is primarily attributed to UBS downgrading the company's rating from "Buy" to "Neutral" and lowering the target price from HKD 490 to HKD 468 [3][7]. Company Performance - As of January 28, Mixue Group's shares fell over 10%, reaching a low of HKD 396 during trading [1]. - The company faces risks of declining gross margins due to rising raw material costs, particularly for key ingredients like lemons, a reduction in delivery subsidies, and intensified industry competition [4][9]. Market Outlook - Despite the downgrade by UBS, domestic institutions remain optimistic about Mixue Group's growth prospects. West Securities noted that the company is accelerating its overseas expansion, with store performance exceeding expectations [4][10]. - Mixue Group plans to open three new stores in the U.S. by December 2025, targeting major cities like Los Angeles and New York. The menu will include high-sweetness options and plant-based milk to cater to local tastes [4][10]. International Expansion - The company is set to open an exclusive overseas franchise channel in November 2025, targeting 16 countries and regions, with Southeast Asia identified as a key area for expansion [5][10]. - In Vietnam, the total cost for a franchise store is approximately 10 billion VND, equivalent to 265,000 RMB, leveraging local supply chains and standardized support systems [5][10]. - Mixue Group has signed a procurement order for 4 billion coffee beans with Brazil, with plans to establish a supply chain factory, aiming to open its first store in São Paulo by March 2026 [5][10]. Financial Projections - West Securities has raised its profit forecasts for Mixue Group, expecting net profits attributable to shareholders to reach 6.1 billion, 7 billion, and 8.1 billion RMB for the years 2025 to 2027, respectively [5][10]. - The current stock price corresponds to a price-to-earnings ratio of 25, 22, and 19 times for the years 2025 to 2027, with a "Buy" rating assigned [5][10].

| | 1月以来券商债券获批情况- | | | | --- | --- | --- | --- | | 公告时间 | 公司简称 | 获批规模 | 债券类型 | | 1月7日 | 首创证券 | 50亿元 | 永续次级公司债 | | 1月12日 | 东方财富证券 | 200亿元 | 次级公司债 | | 1月12日 | 长江证券 | 10亿元 | 科创债 | | 1月13日 | 银河证券 | 300亿元 | 公司债 | | 1月13日 | 申万宏源证券 | 600亿元 | 公司债 | | 1月19日 | 广发证券 | 200亿元 | 永续次级公司债 | | 1月21日 | 银河证券 | 50亿元 | 科创债 | | 1月22日 | 广发证券 | 700亿元 | 公司债 | | 1月26日 | 东北证券 | 100亿元 | 公司债 | | 1月26日 | 西部证券 | 180亿元 | 公司债 | | 1月27日 | 国联民生证券 | 180亿元 | 公司债 | | 1月27日 | 民生证券 | 80亿元 | 公司债 | | 总计 | | 2650亿元 | 数据来源：公司公告 | 除上述案例外，1月26日，西部证券、东 ...

Core Viewpoint - The bond issuance by securities firms has accelerated significantly at the beginning of 2026, with a total of 2,650 billion yuan approved for issuance, reflecting a 216.53% increase compared to the same period in 2025 [1][5][6]. Group 1: Bond Issuance Overview - On January 27, Guolian Minsheng Securities announced the approval to issue bonds totaling 180 billion yuan and its subsidiary Minsheng Securities 80 billion yuan, with approvals valid for 24 months [2][3]. - As of January 26, 2026, securities firms have cumulatively issued bonds amounting to 2,380.3 billion yuan, a significant increase from 752 million yuan in the same period of 2025 [5][6]. - The bond issuance includes various types such as perpetual subordinated bonds and technology innovation bonds, indicating a diversification in the types of bonds being issued [6][7]. Group 2: Market Dynamics and Trends - The surge in bond issuance is attributed to favorable market conditions and the increasing capital needs of securities firms, driven by the overall positive trend in the capital market [5][6]. - The current low interest rate environment provides an advantageous window for securities firms to engage in debt financing, allowing them to enhance their capital adequacy and invest in diversified business areas [5][6]. - The issuance of technology innovation bonds has gained momentum, supported by regulatory policies that encourage financial institutions to fund technology innovation [6][7]. Group 3: Future Outlook - Analysts suggest that the concentrated bond issuance at the beginning of the year is a common practice among securities firms to secure operational capital for the year ahead [7]. - With expectations of a prolonged bull market in China's capital market, securities firms will require more capital to support diversified business operations [7]. - The trend of "Matthew Effect" is evident, where leading securities firms continue to expand their issuance scale, while smaller firms face constraints in financing capabilities [7].

证券日报网讯 1月27日，山外山发布公告称，公司分别于2025年12月3日召开第二届审计委员会第十三 次会议和第三届董事会第二十二次会议，2025年12月22日召开2025年第四次临时股东会审议通过了《关 于部分募投项目调整及新增募投项目的议案》，同意公司本次部分募投项目调整及新增募投项目事项， 同时为确保募集资金使用安全，拟对山外山、重庆天外天生物技术有限公司（简称"天外天"）分别设立 募集资金专项账户，并与保荐人和存放募集资金的银行签署募集资金专户存储监管协议，且由董事会授 权管理层全权办理与本次募集资金专项账户相关后续事宜。为规范本次募集资金的存放、使用与管理， 提高资金使用效率，根据相关法律法规、规范性文件的规定，公司及全资子公司天外天、保荐人西部证 券股份有限公司、招商银行股份有限公司重庆分行签署了《募集资金三方监管协议》。 （编辑 任世碧） ...

数据印证"国家队"实施减持 监管层对市场过热的"精准降温" 开年以来，宽基ETF市场呈现"冰火交织"的局面，交易额持续火爆，资金却在悄然撤离。 Wind数据显示，截至1月26日，股票型ETF年内日均成交额2427亿元，同比实现翻倍，多只宽基ETF成交额刷新历史纪录。另一边，宽基ETF却遭遇大规模 赎回，年内净流出规模累计达7382亿元。多只宽基ETF出现明显资金流出。第一财经根据定期报告计算，仅9只重点宽基ETF的基金份额就较中央汇金等"国 家队"去年底的持仓份额减少近870亿份，这一变动也坐实了"国家队"年初的减持动作。 这场暗流涌动的资金大挪移，实则是监管层对市场过热的"精准降温"。从上调融资保证金比例到证监会遏制过度炒作，一系列降温举措成功给逼近4万亿元 成交额的市场行情"踩了刹车"。 "本轮监管层的出手更接近'节奏管理'，为行情延续创造更稳健的运行环境。"金鹰基金权益研究部宏观策略研究员金达莱对第一财经表示，随着短期交易性 资金降温，市场或有望逐步从"抢主题、拔估值"转向更强调产业趋势与盈利确定性的阶段。 A股市场在波动中延续交易热度，股票型ETF成交额持续放量。Wind统计显示，截至1月26日，全市 ...

每经记者｜陈晨 每经编辑｜彭水萍 2026年开年伊始，A股市场持续活跃，不仅点燃了投资者的热情，也让身处资本市场核心的证券公司面临资金考验。1月26日晚间，东北证券与西部证券分 别获批100亿元和180亿元的公司债注册申请，正式加入券商这场开年"补血"大军。此外，Wind数据显示，仅在1月1日至26日不足一个月的时间里，券商发 债规模已高达2480.2亿元，较去年同期增长了近230%。 记者进一步梳理发现，2026年开年以来，券商融资节奏明显加快。除了上述两家券商外，首创证券、东方财富、长江证券、申万宏源和广发证券等机构的债 券注册申请也先后获批。其中，头部券商的融资规模尤为引人注目：1月13日，申万宏源证券获批发行不超过600亿元公司债；1月22日，广发证券更是拿到 了不超过700亿元的巨额批文。 | 序号 | 类别 7 | 发行只数 T | 只数比重(%)了 | 发行额( | | --- | --- | --- | --- | --- | | 1 | 证券公司债 | 65 | 2.06 | | | 2 | 证券公司短期融资券 | 27 | 0.86 | | | 总和 | | 92 | 2.92 | 2 | ...